GlassScriptPhysician profile
Emre A Eren
NPI 1649776519
$19,290.61
in general payments reported to CMS, 2019-2025
10 companies · $1,579 in 2025
The $1,579 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $858 · 2022: $3,636 · 2023: $986 · 2024: $12K · 2025: $1,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $3,176 · Travel and Lodging: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $3,176.22 |
| Travel and Lodging | $1,619.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,243.97 | 2024 | |
| Rock Medical Orthopedics, INC. | $4,655.78 | 2020-2024 | |
| Stryker Corporation | $2,324.12 | 2023-2025 | T2 Alpha, Prostep, Pangea |
| Smith+Nephew, INC. | $478.36 | 2023-2025 | Taylor Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Trigen Intertan |
| Kerecis Limited | $281.17 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Acumed LLC | $164.42 | 2024-2025 | Acumed, Acumed |
| Medline Industries LP | $57.71 | 2023 | |
| Vericel Corporation | $37.75 | 2023 | Maci |
| Polynovo North America LLC | $31.36 | 2025 | Novosorb Btm |
| Bioventus LLC | $15.97 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emre Eren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.